These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 9490079)
1. H3-receptor antagonists: conformational analysis of thioperamide and x-ray crystal structure of the analog N-cyclohexyl-4-methylpiperidine-1-carbothioamide. Plazzi PV; Bordi F; Mor M; Cozzini P; Domiano P Farmaco; 1997; 52(6-7):399-404. PubMed ID: 9490079 [TBL] [Abstract][Full Text] [Related]
2. In vitro characterization of potency, affinity and selectivity of H3-antagonists: from thioperamide to thioperamide unrelated imidazole derivatives. Barocelli E; Ballabeni V; Caretta A; Bertoni S; Bordi F; Rivara S; Silva C; Mor M; Impicciatore M Farmaco; 1997; 52(6-7):463-9. PubMed ID: 9372599 [TBL] [Abstract][Full Text] [Related]
3. Novel histamine H3 receptor antagonists: synthesis and evaluation of formamidine and S-methylisothiourea derivatives. Goto T; Sakashita H; Murakami K; Sugiura M; Kondo T; Fukaya C Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):305-11. PubMed ID: 9118445 [TBL] [Abstract][Full Text] [Related]
4. Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists. Liedtke S; Flau K; Kathmann M; Schlicker E; Stark H; Meier G; Schunack W Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):43-50. PubMed ID: 12616340 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927 [TBL] [Abstract][Full Text] [Related]
7. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore. Axe FU; Bembenek SD; Szalma S J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of new 1-substitutedmethyl-4-[5-(N-methyl-N-propylamino)pentyloxy]piperidines and selected 1-[(N-substituted-N-methyl)-3-propyloxy]-5-(N-methy-l-N-propyl)-pentanediamines as H3 -antagonists. Masłowska-Lipowicz I; Walczyński K Chem Biol Drug Des; 2014 Jan; 83(1):106-18. PubMed ID: 23957330 [TBL] [Abstract][Full Text] [Related]
9. Thioperamide, a histamine H3 receptor antagonist, increases GABA release from the rat hypothalamus. Yamamoto Y; Mochizuki T; Okakura-Mochizuki K; Uno A; Yamatodani A Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):289-98. PubMed ID: 9379777 [TBL] [Abstract][Full Text] [Related]
10. Ligands of the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type. Plazzi PV; Mor M; Bordi F; Silva C; Rivara S; Caretta A; Ballabeni V; Impicciatore M; Vitali T Farmaco; 1997 May; 52(5):295-302. PubMed ID: 9274000 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists. Kitbunnadaj R; Zuiderveld OP; De Esch IJ; Vollinga RC; Bakker R; Lutz M; Spek AL; Cavoy E; Deltent MF; Menge WM; Timmerman H; Leurs R J Med Chem; 2003 Dec; 46(25):5445-57. PubMed ID: 14640553 [TBL] [Abstract][Full Text] [Related]
12. QSAR study on H3-receptor affinity of benzothiazole derivatives of thioperamide. Bordi F; Mor M; Morini G; Plazzi PV; Silva C; Vitali T; Caretta A Farmaco; 1994 Mar; 49(3):153-66. PubMed ID: 8043166 [TBL] [Abstract][Full Text] [Related]
13. Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold. Vaccaro WD; Sher R; Berlin M; Shih NY; Aslanian R; Schwerdt JH; McCormick KD; Piwinski JJ; West RE; Anthes JC; Williams SM; Wu RL; She HS; Rivelli MA; Mutter JC; Corboz MR; Hey JA; Favreau L Bioorg Med Chem Lett; 2006 Jan; 16(2):395-9. PubMed ID: 16246552 [TBL] [Abstract][Full Text] [Related]
14. Conformational preferences of proline analogues with different ring size. Jhon JS; Kang YK J Phys Chem B; 2007 Apr; 111(13):3496-507. PubMed ID: 17388495 [TBL] [Abstract][Full Text] [Related]
15. Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists. Berlin M; Ting PC; Vaccaro WD; Aslanian R; McCormick KD; Lee JF; Albanese MM; Mutahi MW; Piwinski JJ; Shih NY; Duguma L; Solomon DM; Zhou W; Sher R; Favreau L; Bryant M; Korfmacher WA; Nardo C; West RE; Anthes JC; Williams SM; Wu RL; Susan She H; Rivelli MA; Corboz MR; Hey JA Bioorg Med Chem Lett; 2006 Feb; 16(4):989-94. PubMed ID: 16297617 [TBL] [Abstract][Full Text] [Related]